Sivik Global Healthcare’s Allergan plc AGN Stock Holding History

Sivik Global Healthcare’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-15,000	Closed	-$4.02M	–	69
2016 Q1	$4.02M	Sell	15,000 -2,500	-14%	-$716K	1.78%	23
2015 Q4	$5.47M	Sell	17,500 -2,500	-13%	-$744K	2.6%	10
2015 Q3	$5.44M	Buy	20,000 +100	+0.5%	+$30.7K	2.64%	10
2015 Q2	$6.04M	Sell	19,900 -7,600	-28%	-$2.27M	2.1%	14
2015 Q1	$8.19M	Buy	27,500 +2,700	+11%	+$770K	2.79%	3
2014 Q4	$6.38M	Sell	24,800 -2,700	-10%	-$675K	2.59%	9
2014 Q3	$6.63M	Buy	27,500 +7,500	+38%	+$1.68M	3.02%	5
2014 Q2	$4.46M	Buy	20,000 +10,000	+100%	+$2.07M	2.25%	16
2014 Q1	$2.06M	Sell	10,000 -3,000	-23%	-$594K	1.29%	38
2013 Q4	$2.18M	Buy	+13,000	New	+$2.03M	1.55%	35

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Sivik Global Healthcare's AGN Position: Q2 2016 in Review

Sivik Global Healthcare sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 15,000 shares — an estimated $4.02M sold.

Sivik Global Healthcare first reported a position in AGN in Q4 2013 and held it in 10 quarters. The position peaked at $8.19M in Q1 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

Sivik Global Healthcare reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
Sivik Global Healthcare sold 15,000 Allergan plc shares in Q2 2016, an estimated $4.02M.
Sivik Global Healthcare first reported a position in Allergan plc in Q4 2013 and held it in 10 quarters.
Sivik Global Healthcare's Allergan plc position peaked at $8.19M in Q1 2015.
1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Sivik Global Healthcare's 13F filing for Q2 2016, filed 5 Aug 2016.